DB –– OUTPOST № 66

Give Cancer the Boot:
Supporting Breast Cancer Research

PRESS RELEASES  •   > 4 MIN

An Inside Look on Giving Cancer the Boot

Durango is committed to giving back with our Pink Ribbon Boots. To date, we have donated over a quarter million dollars to Breast Cancer Research and this year, we want to give an inside look at where the money goes and how it’s helping.

Durango donates a percent per pair of Pink Ribbon Boots to the The Stefanie Spielman Fund for Breast Cancer Research at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James).

“The initial goal of the Fund was to deliver hope,” shared Maddie Spielman, Assistant Director of Leadership Annual Giving at The OSUCCC – James and daughter to Stefanie and Chris Spielman. “The idea was that patients would see my mom’s story and that her hope would resonate with at least one person. My mom wanted to be that force that had an impact and helped others to fight this disease.”

In 1998, Stefanie Spielman was diagnosed with breast cancer at the age of 30 and lost her battle with the disease in 2009. Stefanie and her husband Chris Spielman, an All-Star linebacker from Massillon, Ohio and 11-year NFL player, became advocates for the fight against breast cancer, founding the Stefanie Spielman Fund for Breast Cancer Research in 1998. The fund has raised more than $22 million to support research at the OSUCCC – James. To learn more about the Stefanie Spielman Fund for Breast Cancer Research, visit www.spielmanfund.com.

The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute strives to create a cancer-free world by integrating scientific research with excellence in education and patient-centered care, a strategy that leads to better methods of prevention, detection and treatment. Ohio State is one of only 51 National Cancer Institute-designated Comprehensive Cancer Centers and one of only a few centers funded by the NCI to conduct both phase I and phase II clinical trials on novel anticancer drugs. As the cancer program’s 356-bed adult patient-care component, The James is one of the top cancer hospitals in the nation as ranked by U.S. News & World Report and has achieved Magnet designation, the highest honor an organization can receive for quality patient care and professional nursing practice. At 21 floors with more than 1.1 million square feet, The James is a transformational facility that fosters collaboration and integration of cancer research and clinical cancer care. For more information, please visit cancer.osu.edu.